Reversal of fundic atrophy after eradication of Helicobacter pylori

American Journal of Gastroenterology

Volumn 93, Issue 9, 1998, Pages 1425-1431

  Tucci, Antonio ^a,b   Poli, Loris ^a   Tosetti, Cesare ^a   Biasco, Guido ^a   Grigioni, Walter ^a   Varoli, Ornella ^a   Mazzoni, Claudia ^a   Paparo, Giovanni F ^a   Stanghellini, Vincenzo ^a   Caletti, Giancarlo ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATROPHIC GASTRITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; REMISSION; STOMACH ACID SECRETION; STOMACH FUNDUS;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ATROPHY; FEMALE; FOLLOW-UP STUDIES; GASTRIC ACID; GASTRIC EMPTYING; GASTRIC FUNDUS; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS;

EID: 0032172817     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00454.x     Document Type: Article

References (40)

1. 1. Villako K, Tamm A, Savisaar et al. Prevalence of antral and fundic gastritis in a randomly selected group of an Estonian rural population. Scand J Gastroenterol 1976;11:817-22.
2. 2. Samloff M, Varis K, Ihamaki T, et al. Relationship among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 1982;83:204-9.
3. 3. Cheli R, Perasso A, Giacosa A. Dyspepsia and chronic gastritis. Hepato-Gastroenterol 1983;30:21-3.
4. 4. Kreuning J, Bosman FT, Kuiper G, et al. Gastric and duodenal mucosa in healthy individuals. J Clin Pathol 1978;31:69-77.
5. 5. Gutierrez O, Lehy T, Rene E, et al. Epithelial cell proliferation in human fundic and antral mucosae. Influence of superselective vagotomy and relationship with gastritis. Dig Dis Sci 1985;30:1034-42.
6. 6. Uibo R, Krohn K, Villako K, et al. The relationship of parietal cell, gastrin cell, and thyroid autoantibodies to the state of the gastric mucosa in a population sample. Scand J Gastroenterol 1984;19:1075-80.
7. 7. Cheli R, Santi L, Ciancamerla G, et al. A clinical and statistical follow-up of atrophic gastritis. Am J Dig Dis 1973;18:1061-6.
8. 8. Siurala M, Varis K, Wiliasalo M. Studies of patients with atrophic gastritis: A 10-15 year follow-up. Scand J Gastroenterol 1966;1:40-8.
9. 9. Walker IR, Strickland RG, Ungar B, et al. Simple atrophic gastritis and gastric carcinoma. Gut 1971;12:906-11.
10. 10. Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 1985;88: 638-48.
11. 11. Russo A, Buffa R, Grasso G, et al. Gastric gastrinoma and diffuse G-cell hyperplasia associated with chronic atrophic gastritis. Digestion 1980;20:416-9.
12. 12. Carney JA, Go VLW, Fairbanks VF, et al. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med 1983;99:761-6.
13. 13. Sipponen P, Kekki M, Haapakoski J, et al. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-selectional data. Int J Cancer 1985;35:173-7.
14. 14. Correa P, Haenzel W, Cuello C, et al. Gastric precancerous process in a high risk population: cohort follow-up study. Cancer Res 1990;50: 4737-40.
15. 15. Kekki M, Villako K, Tamm A, et al. Dynamics of antral and fundal gastritis in an Estonian rural population sample. Scand J Gastroenterol 1977;12:321-4.
16. 16. Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972;63:584-92.
17. 17. Ihamaki T, Kekki M, Sipponen P, et al. The sequelae and course of chronic gastritis during a 30-to 34-year bioptic follow-up study. Scand J Gastroenterol 1985;20:485-91.
18. 18. Rosch W, Demling L, Elster K. Is chronic gastritis a reversible process? Follow-up study of gastritis by step-wise biopsy. Acta Hepato-Gastroenterol 1975;22:252-5.
19. 19. Cheli R, Dodero M, Celle G. The anatomic bases of gastric secretion. Comparative analysis of biopsy and function findings. Am J Dig Dis 1962;7:922.
20. 20. Varis K, Ihamaki T, Harkonen M, et al. Gastric morphology, function, and immunology in first-degree relatives of probands with pernicious anemia and controls. Scand J Gastroenetrol 1979;14:129-39.
21. 21. Siurala M, Sipponen P, Kekki M. Campylobacter pylori in a sample of Finnish population: Relations to morphology and functions of the gastric mucosa. Gut 1988;29:909-15.
22. 22. Tatsuta M, Iishi H, Okuda S. Gastric emptying and gastrointestinal symptoms in patients with atrophic gastritis and the effects of Domperidone. Scand J Gastroenterol 1989;24:251-6.
23. 23. Davies WT, Kirkpatrik JR, Owen GM, et al. Gastric emptying in atrophie gastritis and carcinoma of the stomach. Scand J Gastroenterol 1971;6:297-301.
24. 24. Halvorsen L, Dotevall G, Walan A. Gastric emptying in patients with achlorhydria or hyposecretion of hydrocloric acid. Scand J Gastroenterol 1973;8:395-9.
25. 25. Karnes WE, Samloff IM, Siurala M, et al. Positive serum antibody and negative tissue staining for Helicobacter pylori in subjects with atrophic body gastritis. Gastroenterology 1991;101:167-74.
26. 26. Tucci A, Stanghellini V, Corinaldesi R, et al. Helicobacter pylori and gastric functions in patients with fundic atrophic gastritis. Gastroenterology 1992;102:A.181 (abstract).
27. 27. Misiewicz JJ, Tytgat GNJ, Goodwin CS, et al. The Sydney system: A new classification of gastritis. World Congress on Gastroenterology. Working Party Reports. Sydney, Blackwell Science Publishing, 1990, 1-10.
28. 28. Tucci A, Corinaldesi R, Stanghellini V, et al. Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology 1992;103:768-74.
29. 29. Borody TJ, Andrews P, Jankiewicz E, et al. Apparent reversal early gastric mucosal atrophy after triple therapy for Helicobacter pylori. Am J Gastroenterol 1993;88:1266-8.
30. 30. Genta RM, Graham DY. Intestinal metaplasia, not atrophy or achlorhydria, creates a hostile environment for Helicobacter pylori. Scand J Gastroenterol 1993;28:924-8.
31. 31. El-Omar EM, Oien K, El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113:15-24.
32. 32. Hattori T, Fujita S. Fractographic study on the growth and multiplication of the gastric gland of the hamster. Cell Tiss Res 1974;153: 145-9.
33. 12 absorption in patients with pernicious anemia. J Clin Invest 1966;45:803-12.
34. 34. Arderman S, Chanarin I. Steroids and addisonian pernicious anemia. N Engl J Med 1965;273:1352.
35. 35. Jorge AD, Sanchez D. The effect of azathioprine on gastric mucosal histology and acid secretion in chronic gastritis. Gut 1973;14:104-6.
36. 36. Bazuro GE, Dezi A, Pallotta L, et al. Effects of sulglycotide on inflammation and epithelial cell turnover in active Helicobacter pylori+ chronic gastritis. Dig Dis Sci 1996;41:22-5.
37. 37. Hui WM, Lam SK, Ho J, et al. Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori. Dig Dis Sci 1991;96:577-82.
38. 38. Rugge M, Casaro M, Leandro G, et al. Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci 1996;41:950-5.
39. 39. El Zimaity HM, Graham DY, Al-Assi MT, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996;27:35-41.
40. 40. Flejou JF, Bogomolets WV, Cales P, et al. Interobserver agreement on histological classification and grading using the Sydney System. Path Res Pract 1993;189:695 (abstract).